Početna › Autoimune bolesti › Arizona
Kliničke studije za Autoimune bolesti u državi Arizona
6 studija za Autoimune bolesti traži sudionike na lokacijama u državi Arizona.
Gradovi u državi Arizona
Službeni tekst studije (engleski)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Sun Valley Arthritis Center Ltd, Peoria
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07621809A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Mayo Clinic, Phoenix
U tijeku regrutacijaFaza 1
Od 18 do 74 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT07085104A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Phoenix Children's Hospital, Phoenix
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT06056297Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1017, Phoenix
- Site Number - 1025, Scottsdale
- Site Number - 1042, Tucson
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 30. srp 2026. · NCT07039916A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Banner MD Anderson Cancer Center, Gilbert
- Phoenix Children's Hospital, Phoenix
- University of Arizona Medical Center - Tucson, Tucson
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 6. srp 2026. · NCT01351545Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- Mayo Clinic, Scottsdale
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 30. lip 2026. · NCT06201416Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.